Sign In to Follow Application
View All Documents & Correspondence

Automatic Oxygen Flow Rate Control Device

Abstract: The oxygen flow control valve is used for controlling the flow rate of oxygen and it also controls and manages the frequency and speed according to L/min. Our device is mainly used in Oxygen flow control of Patient according to Saturation of Patient using Patient Monitor Real Time Saturation readings. The oxygen control valve is connected with the device because it checks and configures the requirement of oxygen flow to the patient. When the oxygen level of SpO2 is normal or gets increased then the flow rate through the controller decreases. This whole system is wirelessly integrated with Remote Monitoring Dashboard software for monitoring the real time Oxygen requirement & flow rate/min. 1-Automatic Oxygen Flow control of patient according to SpO2. 2-Compatible with Oxygen Cylinder & Oxygen Central Line. 3-Integrated with Patient Oxygen Saturation (SpO2). 4-Bidirectional Integration facility. 5-Wireless connectivity. 6-Deliver oxygen flow rate up to 20liter/min.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
23 November 2022
Publication Number
49/2022
Publication Type
INA
Invention Field
BIO-MEDICAL ENGINEERING
Status
Email
dr.bksarkar2003@yahoo.in
Parent Application

Applicants

Eras Lucknow Medical College & Hospital
Eras Lucknow Medical College & Hospital, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India.
American University of Barbados
Add-2: American University of Barbados, St. Michael, Wildey, Bridgetown, Barbados BB11103
Mr. Mohsin Ali Khan
Add-1: Eras Lucknow Medical College & Hospital , Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India. Add-2: American University of Barbados, St. Michael, Wildey, Bridgetown, Barbados BB11103
Mr. Zaw Ali khan
Add-1: Eras Lucknow Medical College & Hospital , Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India. Add-2: American University of Barbados, St. Michael, Wildey, Bridgetown, Barbados BB11103
Ms. Kinza Zehra
Add-1: Eras Lucknow Medical College & Hospital, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India.
Ms. Sarina Zehra
Add-1: Eras Lucknow Medical College & Hospital, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India.

Inventors

1. Mr. Mohsin Ali Khan
Add-1: Eras Lucknow Medical College & Hospital , Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India. Add-2: American University of Barbados, St. Michael, Wildey, Bridgetown, Barbados BB11103
2. Mr. Zaw Ali khan
Add-1: Eras Lucknow Medical College & Hospital , Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India. Add-2: American University of Barbados, St. Michael, Wildey, Bridgetown, Barbados BB11103
3. Ms. Kinza Zehra
Add-1: Eras Lucknow Medical College & Hospital, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India.
4. Ms. Sarina Zehra
Add-1: Eras Lucknow Medical College & Hospital, Sarfarazganj, Hardoi Road, Lucknow, Uttar Pradesh 226003, India.

Specification

FIELD OF THE INVENTION
[501] Our Invention is related to a Automatic Oxygen Flow Rate Control Device.

BACKGROUND OF THE INVENTION
[502] Respiratory treatment comprising of Long haul Oxygen Treatment (LTOT) has been displayed to increment endurance among patients with COPD. During the Nighttime Oxygen Treatment Preliminary (NOTT) consistent oxygen treatment (mean 19 h/d) was looked at versus 12 h/d, and showed a relative decrease in mortality utilizing ceaseless oxygen.

[503] As well as a diminished mortality, other perceived benefits from LTOT remember a decline for hypoxia-prompted heights of hemoglobin, lower pneumonic course pressure and vascular obstruction, expanded stroke volume record, further developed practice resistance, and emotional improvement in personal satisfaction.

[504] Regardless of the positive advantages of LTOT, even brief times of hypoxemia can have unfriendly impacts prompting right ventricular hypertrophy from expanded pneumonic conduit pressure and aspiratory vascular obstruction.

[505] Sadly with the current steady low-stream LT?T, the variable oxygen request may not be all around matched to the oxygen conveyance , Ceaseless oxygen is most regularly conveyed through nasal cannula which can actually convey 100 percent oxygen. During motivation this O2 blends in with room air to build the negligible portion of propelled oxygen (EIO2).

[506] Changing the O2 stream rate will influence the FIO2 with the end goal that every liter each moment roughly expands the FI02. 3 to 4% above room air (American Thoracic Culture. 1995). It isn't prescribed to utilize stream rates more prominent than 4 1/min for constant oxygen treatment through nasal cannula.

[507] Higher stream rates can be accomplished using facial veils. In reality, the last FIO2 will rely upon various patient factors: life structures, shunt part, and respiratory rate.

[508] For steady O2 stream, the FIO2 is conversely corresponding to respiratory rate. By and by, low-stream constant O2 is normally adequate to increment blood vessel oxygen content to clinically satisfactory levels.

PRIOR ART SEARCH

[509] US-20060225737 and[510] EP3578220: Device and method for limiting adverse events during supplemental oxygen therapy are disclosed. In the present invention, the oxygen flow between a patient and an oxygen source is controlled with a valve such as a proportional solenoid capable of constraining flow-rates within a continuous range.

[511] The flow-rate of oxygen is accurately controlled in a closed-loop with flow-rate measurements. Measures of a patient's vital physiological statistics are used to automatically determine optimum therapeutic oxygen flow-rate.
[512] Controller signal filtering is disclosed to improve the overall response and stability. The control algorithm varies flow-rates to minimize disturbances in the patient feedback measurements.
OBJECTIVES OF THE INVENTION
1. The objective of the invention is to provide an Automatic Oxygen Flow control of patient according to SpO2.
2. The other objective of the invention is to provide a Compatible with Oxygen Cylinder & Oxygen Central Line.
3. The other objective of the invention is to provide a Integrated with Patient Oxygen Saturation (SpO2).
4. The other objective of the invention is to provide a Bidirectional Integration facility.
5. The other objective of the invention is to provide a Wireless connectivity.
6. The other objective of the invention is to provide a Deliver oxygen flow rate up to 20liter/min.
SUMMARY OF THE INVENTION
[513] Mechanized oxygen conveyance framework incorporates a sensor to quantify a measure of oxygen in a circulation system of a patient, a pneumatics subsystem and a control subsystem.

[514] The pneumatics subsystem incorporates an oxygen gulf, an air delta, a gas combination outlet, and a gas conveyance system to mix the oxygen and air to shape a gas blend having a conveyed oxygen focus, and to convey the gas combination to the patient.

[515] The control subsystem incorporates an information gadget to get an ideal centralization of oxygen in the circulation system of the patient, a sensor connection point to get estimation information and status data related with the estimation information from the sensor, a pneumatics subsystem connection point to send orders to.

[516] get information from, the pneumatics subsystem, and a processor to control the conveyed oxygen fixation in view of the ideal oxygen focus, the estimation information and the status data.

[517] there has in this manner been framed, rather comprehensively, certain encapsulations of the creation all together that the definite depiction thereof thus might be better perceived, and all together that the current commitment to the craftsmanship might be better valued.

[518] there are, obviously, extra epitomes of the innovation that will be depicted underneath and which will shape the topic of the cases added hereto.

BRIEF DESCRIPTION OF THE DIAGRAM
Fig.1: Automatic Oxygen Flow Rate Control Device Flow. (Prior art).
Fig.2: Automatic Oxygen Flow Rate Control Device Flow Chart (Prior Art).
Fig.3: Automatic Oxygen Flow Rate Control Device.
DESCRIPTION OF THE INVENTION
[519] The oxygen control valve is used for controlling the flow rate of oxygen and it is also controlled and managed the frequency and speed according to l/min.

[520] The oxygen control valve is connected with the device because it checks and configures the requirement of oxygen of the patient.

[521] When the oxygen level of SpO2 is increased then the flow rate of the controller decreases.
[522] There are four modes namely:
1. HIS mode.
2. Automatic mode.
3. Test mode.
4. Manual flow rate.
[523] HIS Mode:
? In HIS mode the PID of the patient is generated.
? We will get the Spo2 level from HIS and then according to SpO2 flow rate can be increases and decrease. We can also set the flow rate according the patient condition.
[524] Automatic SpO2 Mode:
In automatic mode, we will get SpO2 through probes instead of HIS. According to the SpO2 level oxygen flow is maintained.

[525] Test Mode:
In test mode, Spo2 is set and the patient gets oxygen according to the SpO2 level.

[526] Manual Flow Rate Mode:
In manual flow rate mode flow rate is set through the valve, and the flow rate can be adjusted manually according to the patient’s need.

I/WE CLAIMS

1) The oxygen flow control valve is used for controlling the flow rate of oxygen and it also controls and manages the frequency and speed according to L/min. Our device is mainly used in Oxygen flow control of Patient according to Saturation of Patient using Patient Monitor Real Time Saturation readings. The oxygen control valve is connected with the device because it checks and configures the requirement of oxygen flow to the patient. When the oxygen level of SpO2 is normal or gets increased then the flow rate through the controller decreases. This whole system is wirelessly integrated with Remote Monitoring Dashboard software for monitoring the real time Oxygen requirement & flow rate/min. 1-Automatic Oxygen Flow control of patient according to SpO2. 2-Compatible with Oxygen Cylinder & Oxygen Central Line. 3-Integrated with Patient Oxygen Saturation (SpO2). 4-Bidirectional Integration facility. 5-Wireless connectivity. 6-Deliver oxygen flow rate up to 20liter/min
2) According to claim1# the invention is to a Automatic Oxygen Flow control of patient according to SpO2.
3) According to claim1,2# the invention is to a Compatible with Oxygen Cylinder & Oxygen Central Line.
4) According to claim1,2,3# the invention is to a Integrated with Patient Oxygen Saturation (SpO2).
5) According to claim1,2,4# the invention is to a Bidirectional Integration facility.
6) According to claim1,2,4,5# the invention is to a Wireless connectivity.
7) According to claim1,2,3,6# the invention is to a Deliver oxygen flow rate up to 20liter/min.

Documents

Application Documents

# Name Date
1 202211067441-FORM 18A [17-02-2024(online)].pdf 2024-02-17
1 202211067441-IntimationUnderRule24C(4).pdf 2025-01-14
1 202211067441-STATEMENT OF UNDERTAKING (FORM 3) [23-11-2022(online)].pdf 2022-11-23
2 202211067441-FORM 18A [17-02-2024(online)].pdf 2024-02-17
2 202211067441-FORM-9 [26-11-2022(online)].pdf 2022-11-26
2 202211067441-POWER OF AUTHORITY [23-11-2022(online)].pdf 2022-11-23
3 202211067441-COMPLETE SPECIFICATION [23-11-2022(online)].pdf 2022-11-23
3 202211067441-FORM 1 [23-11-2022(online)].pdf 2022-11-23
3 202211067441-FORM-9 [26-11-2022(online)].pdf 2022-11-26
4 202211067441-COMPLETE SPECIFICATION [23-11-2022(online)].pdf 2022-11-23
4 202211067441-DECLARATION OF INVENTORSHIP (FORM 5) [23-11-2022(online)].pdf 2022-11-23
4 202211067441-DRAWINGS [23-11-2022(online)].pdf 2022-11-23
5 202211067441-DECLARATION OF INVENTORSHIP (FORM 5) [23-11-2022(online)].pdf 2022-11-23
5 202211067441-DRAWINGS [23-11-2022(online)].pdf 2022-11-23
6 202211067441-COMPLETE SPECIFICATION [23-11-2022(online)].pdf 2022-11-23
6 202211067441-DRAWINGS [23-11-2022(online)].pdf 2022-11-23
6 202211067441-FORM 1 [23-11-2022(online)].pdf 2022-11-23
7 202211067441-FORM 1 [23-11-2022(online)].pdf 2022-11-23
7 202211067441-FORM-9 [26-11-2022(online)].pdf 2022-11-26
7 202211067441-POWER OF AUTHORITY [23-11-2022(online)].pdf 2022-11-23
8 202211067441-FORM 18A [17-02-2024(online)].pdf 2024-02-17
8 202211067441-POWER OF AUTHORITY [23-11-2022(online)].pdf 2022-11-23
8 202211067441-STATEMENT OF UNDERTAKING (FORM 3) [23-11-2022(online)].pdf 2022-11-23
9 202211067441-IntimationUnderRule24C(4).pdf 2025-01-14
9 202211067441-STATEMENT OF UNDERTAKING (FORM 3) [23-11-2022(online)].pdf 2022-11-23

Search Strategy

1 202211067441E_02-12-2024.pdf